Literature DB >> 3116079

Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.

S A Serrate1, R S Schulof, L Leondaridis, A L Goldstein, M B Sztein.   

Abstract

Thymic hormone preparations have been shown to modulate natural killer (NK) activity in vivo in mice. We have investigated the effects of thymosin fraction 5 (TF5) on the in vitro NK cell activity of highly purified human large granular lymphocytes (LGL). The results indicate that TF5 but not kidney fraction 5 (a preparation used as control) is able to enhance the spontaneous NK activity of normal LGL. In addition, TF5 exhibited additive effects with recombinant interferon-alpha in enhancing NK activity in vitro. TF5 also enhanced interleukin 2 production and interleukin 2 receptor expression as well as interferon-gamma production in mitogen-stimulated LGL. Thymosin-alpha 1, a synthetic polypeptide originally isolated in its native form from TF5, also exhibited enhancing effects on LGL activities, suggesting that it is the active species in TF5. These results indicate that thymic hormones might regulate NK activity through the induction of lymphokine production and receptor expression by LGL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116079

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Neurochemistry of brain neuroendocrine immune system: signal molecules.

Authors:  A Galoyan
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS.

Authors:  C W Tuthill; A Rudolph; Y Li; B Tan; T J Fitzgerald; S R Beck; Y X Li
Journal:  AAPS PharmSciTech       Date:  2000-05-14       Impact factor: 3.246

3.  Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).

Authors:  G Pawelec; E Schneider; G Ehninger; A Rehbein; H Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

Authors:  A M Liberati; S Cinieri; M Fizzotti; M Schippa; S Ascani; V De Angelis; M Senatore; L Palmisano
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

5.  Advances in the Treatment of Hepatitis B and Hepatitis C Nonresponders: A Report of Symposia Presented at the 15th Conference of the Asian Pacific Association for the Study of the LiverAugust 18-21, 2005Bali, Indonesia.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

6.  A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Robert G Gish; Stuart C Gordon; David Nelson; Vinod Rustgi; Israel Rios
Journal:  Hepatol Int       Date:  2009-05-08       Impact factor: 6.047

7.  Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.

Authors:  E Garaci; A Mastino; F Pica; C Favalli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.

Authors:  P di Francesco; R Gaziano; I A Casalinuovo; L Belogi; A T Palamara; C Favalli; E Garaci
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

9.  Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?

Authors:  F Kierszenbaum; H Mejia Lopez; M B Sztein
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias.

Authors:  I Munno; M Marinaro; A Gesario; B Cannuscio; Y Michel; E Paulling
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.